Attached files
| file | filename |
|---|---|
| EX-32.1 - EXHIBIT 32.1 CEO 906 CERT FY2020 - BOSTON SCIENTIFIC CORP | exhibit321-ceo906202010xk.htm |
| EX-31.2 - EXHIBIT 31.2 CFO 302 CERT FY2020 - BOSTON SCIENTIFIC CORP | exhibit312-cfo302202010xk.htm |
| EX-31.1 - EXHIBIT 31.1 CEO 302 CERT FY2020 - BOSTON SCIENTIFIC CORP | exhibit311-ceo302202010xk.htm |
| EX-23 - EXHIBIT 23 EY CONSENT FY2020 - BOSTON SCIENTIFIC CORP | exhibit23-2020eyconsent.htm |
| EX-21 - EXHIBIT 21 FY2020 LIST OF SUBSIDIARIES DATED JAN 31, 2021 - BOSTON SCIENTIFIC CORP | exhibit21-listofsubsidiari.htm |
| EX-4.2 - EXHIBIT 4.2 DESCRIPTION OF REGISTERED SECURITIES FY2020 - BOSTON SCIENTIFIC CORP | exhibit42-descriptionofthe.htm |
| 10-K - 10-K - BOSTON SCIENTIFIC CORP | bsx-20201231.htm |
EXHIBIT 32.2
CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C.
SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE
SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report on Form 10-K of Boston Scientific Corporation (the “Company”) for the period ending December 31, 2020 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned Chief Financial Officer of the Company hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that based on his knowledge:
| (1) | the Report fully complies with the requirements of Section 13 (a) or 15 (d) of the Securities Exchange Act of 1934; and | |||||||
| (2) | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Boston Scientific Corporation. | |||||||
| By: | /s/ Daniel J. Brennan | |||||||
| Daniel J. Brennan | ||||||||
| Executive Vice President and Chief Financial Officer | ||||||||
| February 23, 2021 | ||||||||